Clinical Outcomes of Pencil Beam Scanning Proton Therapy in Locally Advanced Non-Small Cell Lung Cancer: Propensity Score Analysis
08/07/2021
/
Publications
/
Chemotherapy
IMRT
This study retrospectively reviewed 219 patients with stage III NSCLC who received definitive concurrent chemoradiotherapy. 25 patients (11.4%) underwent PBSPT...
Hypofractionated Proton Therapy With Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase I Trial From the University of Florida and Proton Collaborative Group.
03/04/2020
/
Publications
/
Hypofractionation
Chemotherapy
Published in the Red Journal, this study reported the safety data from the first multicenter phase I trial investigating the use of hypofractionated proton...
Clinical outcomes after IMPT with concurrent chemotherapy for inoperable NSCLC.
03/04/2019
/
Publications
/
Chemotherapy
Published in the Green Journal, this study by MD Anderson reported disease control, survival, and toxicity in patients with advanced inoperable non-small cell...
Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma (EC).
11/06/2017
/
Publications
/
IMPT
Chemotherapy
Toxicity
19 patients with EC treated with IMPT concurrently with chemotherapy. Clinical complete response was achieved in 84%.
The most common grade 3 acute toxicities...
PRONTOX – a randomized control trial.
10/11/2016
/
Publications
/
Chemotherapy
Although radiochemotherapy with photons is the standard treatment for now for locally advanced NSCLC, but acute radiation-induced toxicity such as esophagitis...
Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer.
11/11/2021
/
Publications
/
Chemotherapy
This study reported outcomes of 25 patients with limited-stage small cell lung cancer treated with combined proton and carbon-ion radiotherapy. Proton and...
Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report.
07/02/2022
/
Publications
/
Chemotherapy
A group of researchers from Japan reported a rare case of oligorecurrent esophageal cancer in complete remission for 5 years after a course of definitive proton...
Treating thoracic cancers with proton therapy
05/06/2019
/
White Paper
/
Chemotherapy
Worldwide, lung cancer is the most common cancer among men in both incidence and...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.